This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Nissan Chemical Corporation, Shionogi & Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 262 
1 out of 16 Years Active: 2026
Title: Masahiro Kamaura: Pharmaceutical Invention and Patent
Introduction
Masahiro Kamaura is an inventor associated with Funabashi, Japan. His patent work includes a pharmaceutical invention focused on inhibiting sepiapterin reductase, an enzyme target relevant to pain treatment.
Latest Patents
Kamaura is associated with 1 patent: “Substituted pyrazolo[1,5-a]pyrimidines as sepiapterin reductase inhibitors.” The patent describes condensed heterocyclic compounds with sepiapterin reductase inhibitory activity and potential use in treating pain. It also covers tautomers, pharmaceutically acceptable salts, and solvates of the compounds.
Career Highlights
Kamaura’s listed company affiliations include Nissan Chemical Corporation and Shionogi & Co., Ltd. His patent reflects work at the intersection of medicinal chemistry and pharmaceutical research.
Collaborations
Kamaura’s listed coworkers include Yusuke Inaba and Yusuke Shintani.
Conclusion
Masahiro Kamaura’s patent on substituted pyrazolo[1,5-a]pyrimidines highlights a pharmaceutical approach to sepiapterin reductase inhibition and potential pain treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile